Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor Compounds

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1431-1435

  Schmitz, John C ^a,b   Chen, Tian Min ^a   Chu, Edward ^a  

^a YALE CANCER CENTER   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 [[(1,2 DIHYDRO 3 METHYL 1 OXOBENZO[F]QUINAZOLIN 9 YL)METHYL]AMINO] 1 OXO 2 ISOINDOLINYL]GLUTARIC ACID; 5' FLUORO 2' DEOXYURIDINE; COMPLEMENTARY DNA; DOUBLE STRANDED RNA; DOXYCYCLINE; MONOCLONAL ANTIBODY; RALTITREXED; SMALL INTERFERING RNA; THYMIDYLATE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; WESTERN BLOTTING;

CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HUMANS; RNA, DOUBLE-STRANDED; RNA, SMALL INTERFERING; THYMIDYLATE SYNTHASE;

EID: 1242316160     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1203     Document Type: Article

References (34)

1. Bernstein, E., Denli, A. M., and Hannon, G. J. The rest is silence. RNA, 7: 1509-1521, 2001.
2. Sharp, P. A. RNA interference-2001. Genes Dev., 15: 485-490, 2001.
3. Zamore, P. D. RNA interference: listening to the sound of silence. Nat. Struct. Biol., 8: 746-750, 2001.
4. Hall, I. M., Noma, K., and Grewal, S. I. RNA interference machinery regulates chromosome dynamics during mitosis and meiosis in fission yeast. Proc. Natl. Acad. Sci. USA, 100: 193-198, 2003.
5. Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I., and Martienssen, R. A. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science (Wash. DC), 297: 1833-1837, 2002.
6. Caudy, A. A., Myers, M., Hannon, G. J., and Hammond, S. M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev., 16: 2491-2496, 2002.
7. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (Lond.), 391: 806-811, 1998.
8. Hamilton, A. J., and Baulcombe, D. C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (Wash. DC), 286: 950-952, 1999.
9. Elbashir, S. M., Lendeckel, W., and Tuschl, T. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev., 15: 188-200, 2001.
10. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101: 25-33, 2000.
11. Hammond, S. M., Bernstein, E., Beach, D., and Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature (Lond.), 404: 293-296, 2000.
12. Williams, B. R. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans., 25: 509-513, 1997.
13. Nilsen, T. W., Maroney, P. A., Robertson, H. D., and Baglioni, C. Heterogeneous nuclear RNA promotes synthesis of (2′, 5′ )oligoadenylate and is cleaved by the (2′, 5′ )oligoadenylate-activated endoribonuclease. Mol. Cell Biol., 2: 154-160, 1982.
14. Player, M. R., and Torrence, P. F. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther., 78: 55-113, 1998.
15. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
16. Carreras, C. W., and Santi, D. V. The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem., 64: 721-762, 1995.
17. Danenberg, P. V. Thymidylate synthetase-a target enzyme in cancer chemotherapy. Biochim. Biophys. Acta, 473: 73-92, 1977.
18. Hardy, L. W., Finer-Moore, J. S., Montfort, W. R., Jones, M. O., Santi, D. V., and Stroud, R. M. Atomic structure of thymidylate synthase: target for rational drug design. Science (Wash. DC), 235: 448-455, 1987.
19. Shoichet, B. K., Stroud, R. M., Santi, D. V., Kuntz, I. D., and Perry, K. M. Structure-based discovery of inhibitors of thymidylate synthase. Science (Wash. DC), 259: 1445-1450, 1993.
20. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA, 88: 8977-8981, 1991.
21. Chu, E., and Allegra, C. J. The role of thymidylate synthase as an RNA binding protein. Bioessays, 18: 191-198, 1996.
22. Chu, E., and Allegra, C. J. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-γ. Adv. Exp. Med. Biol., 339: 143-151, 1993.
23. Keyomarsi, K., Samet, J., Molnar, G., and Pardee, A. B. The thymidylate synthase inhibitor, IC1 D1694, overcomes translational detainment of the enzyme. J. Biol. Chem., 268: 15142-15149, 1993.
24. Van der Wilt, C. L., Pinedo, H. M., Smid, K., and Peters, G. J. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res., 52: 4922-4928, 1992.
25. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
26. Chu, E., Zinn, S., Boarman, D., and Allegra, C. J. Interaction of γ-interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res., 50: 5834-5840, 1990.
27. Chu, E., Voeller, D., Koeller, D. M., Drake, J. C., Takimoto, C. H., Maley, G. F., Maley, F., and Allegra, C. J. Identification of an RNA binding site for human thymidylate synthase. Proc. Natl. Acad. Sci. USA, 90: 517-521, 1993.
28. Keyomarsi, K., and Moran, R. G. Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. J. Biol. Chem., 263: 14402-14409, 1988.
29. Berg, R. W., Ferguson, P. J., Vincent, M. D., and Koropatnick, D. J. A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance. Cancer Gene Ther., 10: 278-286, 2003.
30. Schmitz, J. C., Yu, D., Agrawal, S., and Chu, E. Effect of 2′-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells. Nucleic Acids Res., 29: 415-422, 2001.
31. Swain, S. M., Lippman, M. E., Egan, E. F., Drake, J. C., Steinberg, S. M., and Allegra, C. J. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J. Clin. Oncol., 7: 890-899, 1989.
32. Kitchens, M. E., Forsthoefel, A. M., Rafique, Z., Spencer, H. T., and Berger, F. G. Ligand-mediated induction of thymidylate synthase occurs by enzyme stabilization. Implications for autoregulation of translation. J. Biol. Chem., 274: 12544-12547, 1999.
33. Copur, S., Aiba, K., Drake, J. C., Allegra, C. J., and Chu, E. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochem. Pharmacol., 49: 1419-1426, 1995.
34. Schmitz, J. C., Liu, J., Lin, X., Chen, T. M., Yan, W., Tai, N., Gollerkeri, A., and Chu, E. Translational regulation as a novel mechanism for the development of cellular drug resistance. Cancer Metastasis Rev., 20: 33-41, 2001.